Moreover, NR3C2, CAMK4, and TRAT1 were identified as the candidate genes regulating the level of the circulating Th cells in CRC patients, which will be the focus of future studies in our laboratory. This evidence concerns the gene TRAT1 and colorectal carcinoma.